Results 41 to 50 of about 3,193 (201)
Acquired haemophilia A (AHA) is a rare complication of malignancy. We report a case of AHA secondary to colorectal cancer which presented as post‐operative bleeding, progressive activated partial thromboplastin time prolongation, precipitous factor VIII (FVIII) decline and inhibitor development.
Benjamin Reardon +2 more
wiley +1 more source
A survey of patient blood management for patients undergoing cardiac surgery in nine European countries [PDF]
Study objective: To describe and compare patient blood management (PBM) practices in cardiac surgery in nine European countries and identify the main risk factors for bleeding or transfusion according to the surveyed centres. Design: We set up an online
Andrew Klein +23 more
core +1 more source
Medical treatment for heavy menstrual bleeding
Heavy menstrual bleeding, or menorrhagia, is subjectively defined as a “complaint of a large amount of bleeding during menstrual cycles that occurs over several consecutive cycles” and is objectively defined as menstrual blood loss of more than 80 mL per
Yi-Jen Chen +6 more
doaj +1 more source
Study evaluated the effectiveness and safety of topical tranexamic acid in breast surgery. Topical TXA reduced postoperative haematoma risk by 75% and significantly decreased postoperative drain output compared with controls, while seroma rates were unchanged.
Sina Sobhanmanesh +2 more
wiley +1 more source
A review of European guidelines for patient blood management with a particular emphasis on antifibrinolytic drug administration for cardiac surgery [PDF]
The concept of patient blood management (PBM) was introduced by the World Health Organization in 2011 and is defined as a "patient-focused, evidence-based and systematic approach for optimizing the management of patients and transfusion of blood products
Griffin, Michael +19 more
core +1 more source
Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery?
International audienceStudies have shown that antifibrinolytic (aprotinin, tranexamic acid, epsilon-aminocaproic acid) reduce blood loss in orthopedic surgery. However, most lacked sufficient power to evaluate the efficacy and safety on clinical outcomes.
Mismetti, Patrick +7 more
core +2 more sources
Background No treatment other than platelet administration is known to protect against spontaneous hemorrhage in thrombocytopenic dogs. Objectives Primary: determine if treatment with ε‐aminocaproic acid (EACA) decreases the requirement for blood ...
Johanna Wolf +3 more
doaj +1 more source
Introduction: The Antifibrinolytic Trialists Collaboration aims to increase knowledge about the effectiveness and safety of antifibrinolytic treatment by conducting individual patient data (IPD) meta-analyses of randomised trials.
Katharine Ker +7 more
doaj +1 more source
Enhancing the Evidence for Care in Underserved Bleeding Disorders Communities
ABSTRACT Background Major advances in haemophilia care have not translated equitably across all populations. Individuals with rare bleeding disorders (RBDs), people living in low‐ and lower‐middle‐income countries (LMICs) and women and girls with inherited bleeding disorders (WGWBD) continue to face significant diagnostic, therapeutic and research ...
Johnny Mahlangu
wiley +1 more source
Glanzmann thrombasthenia is a rare genetic disorder. It is of autosomal inheritance. It usually presents as ecchymoses, petechiae, gum bleeding, musical bleeding, and menorrhagia.
Abhay Kumar and Subash Chander Saha
core +1 more source

